Wells Fargo & Co. (WFC) Earnings Analysis

Wells Fargo & Co. (WFC) delivered mixed results in FY2026 on revenue of $103.1B versus the $99.9B estimate (+12.6% YoY) and EPS of $1.29. Below is the full Wells Fargo & Co. earnings breakdown — the risk-adjusted verdict, price forecast, technicals, options and hedge-fund 13F holdings, decoded in plain English.

Wells Fargo & Co. (WFC) Earnings Analysis — key stats

Next earnings dateFeb 4, 2025
Latest reported quarterFY2026
Earnings verdictMixed
Revenue$103.1B (vs $99.9B est · +3.2% surprise · +12.6% YoY)
EPS$1.29 (vs $1.37 est · -5.8% surprise · +37.2% YoY)
Share price$158.16 (+2.1%)
Market cap$1.66T

What you'll find

Frequently asked questions

When is Wells Fargo & Co.'s next earnings date?
Wells Fargo & Co.'s (WFC) next scheduled earnings date is Feb 4, 2025. Magnisto shows the confirmed date, the options-implied expected move and the revenue and EPS estimates Wall Street is modeling into the report.
Did Wells Fargo & Co. (WFC) beat or miss earnings?
In FY2026, Wells Fargo & Co. (WFC) posted mixed results — revenue of $103.1B versus the $99.9B estimate (+3.2% surprise) and EPS of $1.29 versus $1.37 expected (-5.8% surprise). Magnisto decodes every Wells Fargo & Co. (WFC) report into a clear Beat, Miss, In-line or Mixed verdict and checks whether guidance was raised, held or cut.
What is the forecast for Wells Fargo & Co. (WFC) stock?
Magnisto blends analyst price targets, quantitative research, technical trend and options-implied moves into a scenario range for Wells Fargo & Co. (WFC), anchored to the current $158.16 share price, so you can weigh the bull, base and bear cases for Wells Fargo & Co. side by side.
Is Wells Fargo & Co. (WFC) a buy right now?
Magnisto does not give buy or sell tips. It gives you the institutional-grade evidence — the verdict, valuation, risks, technicals and hedge-fund 13F flows — so you can decide whether Wells Fargo & Co. fits your own thesis and risk profile. This is research, not investment advice.

Related stocks

Educational research, not investment advice. Figures are illustrative and may be delayed.